Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
31.28%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 3.33Close
$ 1.26 - $ 4.19 52-Week Range
Ticker Information
Ticker
MGXCompany Name
METAGENOMI INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMETAGENOMI INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MGX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 10.56M | 31.28% | $ 33.77M |
| 3/31/2025 | $ 10.28M | 22.72% | $ 45.26M |
| 12/31/2024 | $ 10.05M | 19.22% | $ 52.3M |
| 9/30/2024 | $ 9.68M | 17.57% | $ 55.08M |
| 12/31/2023 | $ 8.41M | 18.8% | $ 44.76M |
| 12/31/2022 | $ 3.02M | 17.59% | $ 17.2M |
Key Performance Insights, Last 5 Years
- METAGENOMI INC's latest trailing twelve months (TTM) DepAmor % stands at 17.59%.
- Over the past 5 years, METAGENOMI INC's average DepAmor % has been 21.2%.
- The median DepAmor % for METAGENOMI INC during this period was 19.01%
- METAGENOMI INC reached its highest DepAmor % over the past 5 years at 31.28%.
- The lowest DepAmor % recorded by METAGENOMI INC in the same timeframe 17.57%
METAGENOMI INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for METAGENOMI INC is calculated as follows: DepAmor [ $ 3.02M ] / Revenues [ $ 17.2M ]
(=) DepAmor % [ 17.59% ] MGX - Depreciation and Amortization Margin, Last 5 years
17.57%
Minimum
Sep 30, 2024
31.28%
Maximum
Jun 30, 2025
21.2%
Average
19.01%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |